Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 12, 2026Reported purchase · Form 4ALBERT BOURLA, Chairman & CEO · $1.0MOpen the filing ↗
- Aug 5, 2026Reported purchase · Form 4Mortimer J Buckley · $960.4KOpen the filing ↗
- Aug 5, 2026Reported purchase · Form 4RONALD E BLAYLOCK · $998.8KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record5,9443 flagged findings
Reported transactions (Form 4)80since Feb 27, 2025 · and 28 other holdings
Corporate events (8-K)30since Oct 1, 2018
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-05Department of Justice inquiryrecentOpen filing ↗“…complaints filed in federal and state court by private and governmental plaintiffs against Pfizer, Greenstone, and a number of…”
+1 more passage from the same document
- “…of other defendants. These related civil lawsuits assert allegations that generally overlap with those asserted by the State…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 5,944)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 16, 26Form 4 ↗Insider transaction new
- Oct 16, 26SCHEDULE 13G ↗Passive stake new
Insider transaction · 10 Form 4 filings newshow all 10hide
- Oct 14, 26Form 4 ↗Insider transaction new
- Oct 1, 26Form 4 ↗Insider transaction
- Sep 29, 26Form 4 ↗Insider transaction
- Sep 29, 26Form 4 ↗Insider transaction
- Sep 29, 26Form 4 ↗Insider transaction
- Sep 29, 26Form 4 ↗Insider transaction
- Sep 29, 26Form 4 ↗Insider transaction
- Sep 29, 26Form 4 ↗Insider transaction
- Sep 16, 26Form 4 ↗Insider transaction
- Sep 1, 26Form 4 ↗Insider transaction
- Aug 28, 26Form 3 ↗Insider transaction
- Aug 4, 2610-Q ↗Quarterly report
- Aug 4, 268-K ↗Current report · Results
5,944 filings on record, the oldest from Mar 25, 94.
Listing the 25 most recent filings of the 5,944 on record.
92156
- Jun 18, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 29, 25Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
4 senior executive changes2024show all 4hide
- Oct 15, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 26, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 10, 24A senior executive left or was appointed8-K 5.02 ↗
- Jul 1, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 22, 24Restructuring plan with committed costs8-K 2.05 ↗
- Dec 14, 23Completed an acquisition or disposal+2 more in the same filing8-K/A 2.01 ↗
- Dec 12, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 13, 23Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Jul 27, 23A senior executive left or was appointed8-K 5.02 ↗
- Mar 13, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
4 senior executive changes2021 – 2022show all 4hide
- Apr 12, 22A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Dec 15, 21A senior executive left or was appointed8-K 5.02 ↗
- Nov 19, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 9, 21A senior executive left or was appointed8-K 5.02 ↗
- Nov 20, 20Completed an acquisition or disposal+2 more in the same filing8-K 2.01 ↗
- Nov 13, 20Sold unregistered shares+2 more in the same filing8-K 3.02 ↗
11 older filings not shown · The record reaches back to Jan 19, 05.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Feb 1, 11Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Oct 18, 07Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Apr 19, 05Write-down of assets+2 more in the same filing8-K 2.06 ↗
- Jan 19, 05Write-down of assets+2 more in the same filing8-K 2.06 ↗
The full record holds 9 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Vanguard Capital Management7.5%Mar 31, 26SCHEDULE 13G ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Stock compensation, tax and giftsshow the 34 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Mar 4, 26Tax$22KJENNIFER B. DAMICOSVP & Controller↗
- Mar 3, 26Compensationamount n/aJENNIFER B. DAMICOSVP & Controller↗
- Mar 3, 26Compensationamount n/aJENNIFER B. DAMICOSVP & Controller↗
- Feb 27, 26Tax$18KJENNIFER B. DAMICOSVP & Controller↗
- Feb 26, 26Tax$95KMichael McDermottExecutive Vice President↗
- Feb 25, 26Compensationamount n/aCHRISTOFFEL BOSHOFFPresident, R&D↗
- Feb 25, 26Tax$185KCHRISTOFFEL BOSHOFFPresident, R&D↗
- Feb 25, 26Compensation$1.3MMichael McDermottExecutive Vice President↗
- Feb 25, 26Tax$18KMichael McDermottExecutive Vice President↗
- Feb 25, 26Tax$970KMichael McDermottExecutive Vice President↗
- Feb 25, 26Compensation$1.9MLidia FonsecaExecutive Vice President↗
- Feb 25, 26Tax$29KLidia FonsecaExecutive Vice President↗
- Feb 25, 26Tax$1.5MLidia FonsecaExecutive Vice President↗
- Feb 25, 26Compensation$16.6MALBERT BOURLAChairman & CEO↗
- Feb 25, 26Tax$225KALBERT BOURLAChairman & CEO↗
- Feb 25, 26Tax$12.6MALBERT BOURLAChairman & CEO↗
- Feb 25, 26Compensation$594KJENNIFER B. DAMICOSVP & Controller↗
- Feb 25, 26Tax$10KJENNIFER B. DAMICOSVP & Controller↗
- Feb 25, 26Tax$449KJENNIFER B. DAMICOSVP & Controller↗
- Feb 25, 26Compensation$4.2MDOUGLAS M LANKLERExecutive Vice President↗
- Feb 25, 26Tax$60KDOUGLAS M LANKLERExecutive Vice President↗
- Feb 25, 26Tax$3.1MDOUGLAS M LANKLERExecutive Vice President↗
- Feb 25, 26Compensation$1.9MPAYAL SAHNIExecutive Vice President↗
- Feb 25, 26Tax$29KPAYAL SAHNIExecutive Vice President↗
- Feb 25, 26Tax$1.5MPAYAL SAHNIExecutive Vice President↗
- Feb 23, 26Tax$11KJENNIFER B. DAMICOSVP & Controller↗
- Feb 23, 26Tax$22KCHRISTOFFEL BOSHOFFPresident, R&D↗
- Jan 30, 26Tax$341KCHRISTOFFEL BOSHOFFPresident, R&D↗
- Mar 4, 25Compensationamount n/aJENNIFER B. DAMICOSVP & Controller↗
- Feb 27, 25Compensation$18.2MALBERT BOURLAChairman & CEO↗
- Feb 27, 25Tax$478KALBERT BOURLAChairman & CEO↗
- Feb 27, 25Tax$14.2MALBERT BOURLAChairman & CEO↗
- Feb 27, 25Compensation$2.3MLidia FonsecaExecutive Vice President↗
- Feb 27, 25Tax$44KLidia FonsecaExecutive Vice President↗
The full record holds 187 transactions and goes back to Dec 30, 22.
Its sector and its market
Pfizer Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Pfizer Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Pfizer Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 5,944 documents on file, from Mar 25, 1994 to Oct 16, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.